Deal History
About us
Selskabet
Team
Vores kontorer
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Equity Research
Vækstkapital
IPO Strategi og forberedelse
Industrifokus
Business Services
Consumer / Retail / E-commerce
Industrials
Life Science og Healthcare
Software
Career
Events
Insights
News
Company news
Deal news
Carlsquare in the Media
Newsletter
Kontakt
Newsletter
DA
INT
DE
FR
SV
US
Main menu button
Team
Deals
Kontakt
Team
Deals
Kontakt
News
Alle
Company news
Deal News
Equity Research
Events
I Medier
Insights
Macro and markets
Alle
Abera Bioscience
All for One Group
ALM Equity
Alzecure Pharma
Angler Gaming
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
Elicera Therapeutics
Enrad
Frequentis
Future Gaming
GHP Specialty Care
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Risk Intelligence
SBB i Norden
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Zinzino
Alle
07 dec 2023
Equity Research Mindark PE, Q3 2023: Growth as expected
Equity Research
06 dec 2023
Equity Research Update Svenska Aerogel, Q3 2023: Accelerating order intake and new supplier deal
Equity Research
Svenska Aerogel
06 dec 2023
Carlsquare weekly market letter: Follow the junk
Equity Research
Carlsquare
04 dec 2023
Equity research HANZA: Largest acquisition yet looks promising
Equity Research
Hanza
04 dec 2023
Equity Research Update Kancera, Q3 2023: Pending decisive outcome
Equity Research
Kancera
29 nov 2023
Equity research Candles, Q2 2023/2024: Maintained profitability in soft market
Equity Research
Candles Scandinavia
29 nov 2023
Carlsquare weekly market letter: Time for China and gold?
Equity Research
Carlsquare
28 nov 2023
Equity Research Mindark PE, First impression Q3 2023: Revenues as expected, but still high capitalized development costs
Equity Research
24 nov 2023
Equity Research Svenska Aerogel, first impression Q3 2023: Revenues still at low levels, but promising order intake
Equity Research
Svenska Aerogel
22 nov 2023
Carlsquare weekly market letter: Time for a break
Equity Research
Carlsquare
17 nov 2023
Equity research Zinzino, Q3 2023: Impressive profitability
Equity Research
Zinzino
16 nov 2023
Research update Q3 2023: New collaborations bodes well
Equity Research
Abera Bioscience
16 nov 2023
Equity research Nosa Plugs Q3, 2023: Moving ahead of schedule
Equity Research
Nosa Plugs
16 nov 2023
Equity research Zinzino, Q3 2023: Yet another quarter with impressive profitability
Equity Research
Zinzino
15 nov 2023
MrktBUZZ Svenska Aerogel: Major order received - with further potential
Equity Research
Svenska Aerogel
15 nov 2023
Analys Candles Scandinavia: Nya EBITDA-mål på mellan 15 och 17%
Equity Research
Candles Scandinavia
15 nov 2023
Carlsquare weekly market letter: Risk is back in the game
Equity Research
Carlsquare
14 nov 2023
Equity Research SBB, Q3 2023: Further financial strengthening
Equity Research
SBB i Norden
13 nov 2023
Equity Research ALM Equity, Q3 2023: Strong cash position, good in a weak construction market
Equity Research
ALM Equity
13 nov 2023
Analys Spotlight Group, första intrycket kv3 2023: Utfall under vår förväntan och fortsatt tuff marknad ut 2023
Equity Research
Spotlight Group
1
…
17
18
19
20
21
…
64